These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 796807)

  • 1. Inhibition of platelet aggregation by cationic protein from polymorphonuclear leukocytes.
    Wautier JL; Souchon H; Caen JP
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():23-6. PubMed ID: 796807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Pathol Biol (Paris); 1975 Dec; 23 suppl():33-6. PubMed ID: 817252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
    Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
    Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case.
    László E; Péterfy M; Puskás E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of platelet activation by the amyloid P-component of serum.
    Fiedel BA; Ku CS; Izzi JM; Gewurz H
    J Immunol; 1983 Sep; 131(3):1416-9. PubMed ID: 6886420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.